Project Details
Description
Liver fluke in cattle and sheep represents an increasing economic problem, particularly because of developing resistance to available drugs, as well as representing a serious animal welfare issue. This project will develop a nature based alternative treatment by using a bulk chemical that can be isolated in large quantities from a common non-food plant which is currently little used in the UK and often controlled by burning. The plant material, which itself is know to be actve against fluke, will be converted into a single chemical entity by simple processes and then modified to optimise its activity. This will be determined using a highly specialised approach measuring in vitro many individual effects on the fluke, and during small in vivo studies. The consortium will develop and cost a complete product dossier, including material supply, product formulation, efficacy and delivery systems, a route to market,and an analysis of the potential benefits in controlling disease; it is expected that this project portfolio will either lead to a consortium partner moving directly to the process of full product registration , or to the consortium licencing the outputs so that such a process could begin.
| Status | Finished |
|---|---|
| Effective start/end date | 01 Apr 2015 → 31 Mar 2018 |
Funding
- Innovate UK (102101): £188,498.00
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Research output
- 4 Article
-
Anthelmintic evaluation of triterpenes derived from conifers (family Pinaceae) on the digenean parasite Fasciola hepatica
Chakroborty, A., Dankwa, B., Crusco, A., Forde-Thomas, J. E., Abeysekara, S., Kiwanuka, Z., Ley, M., Davey, S. D., Hollinshead, J., Bartholomew, B., Wild, C., Fenn, C., Thomas, D. A., Holdsworth, P., Fisher, M., Baird, M. S., Nash, R. J. & Hoffmann, K. F., 30 Sept 2025, In: Fitoterapia. 185, 11 p., 106762.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)4 Downloads (Pure) -
Modified Hederagenin Derivatives Demonstrate Ex Vivo Anthelmintic Activity against Fasciola hepatica
Chakroborty, A., Pritchard, D., Bouillon, M. E., Cervi, A., Kraehenbuehl, R., Wild, C., Fenn, C., Holdsworth, P. A., Capner, C., Padalino, G., Forde-Thomas, J., Payne, J., Smith, B. G., Fisher, M., Lahmann, M., Baird, M. S. & Hoffmann, K., 03 Jul 2023, In: Pharmaceutics. 15, 7, 15 p., 1869.Research output: Contribution to journal › Article › peer-review
Open AccessFile5 Citations (Scopus)77 Downloads (Pure) -
Flukicidal effects of abietane diterpenoid derived analogues against the food borne pathogen Fasciola hepatica.
Chakroborty, A., Pritchard, D., Bouillon, M. E., Cervi, A., Cookson, A., Wild, C., Fenn, C., Payne, J., Holdsworth, P., Capner, C., O'Neill, J., Padalino, G., Forde-Thomas, J., Gupta, S., Smith, B. G., Fisher, M., Lahmann, M., Baird, M. S. & Hoffmann, K. F., 30 Sept 2022, In: Veterinary Parasitology. 309, 9 p., 109766.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Citations (Scopus)113 Downloads (Pure) -
An Abeis procera-derived tetracyclic triterpene containing a steroid-like nucleus core and a lactone side chain attenuates in vitro survival of both Fasciola hepatica and Schistosoma mansoni
Whiteland, H., Chakroborty, A., Forde-Thomas, J., Crusco, A., Cookson, A., Hollinshead, J., Fenn, C., Bartholomew, B., Holdsworth, P. A., Fisher, M., Nash, R. J. & Hoffmann, K., 01 Dec 2018, In: International Journal for Parasitology: Drugs and Drug Resistance. 8, 3, p. 465-474 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile30 Citations (Scopus)187 Downloads (Pure)